180 related articles for article (PubMed ID: 3510398)
21. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
22. A divergent cDNA homologue of the c-myc proto-oncogene in the eastern oyster Crassostrea virginica: implications for Myc evolution.
Marsh AG; Chen TT
Mol Mar Biol Biotechnol; 1995 Jun; 4(2):185-92. PubMed ID: 7773336
[TBL] [Abstract][Full Text] [Related]
23. An unusual alteration in c-myc in tissue from a primary breast carcinoma.
Varley JM; Wainwright AM; Brammar WJ
Oncogene; 1987; 1(4):431-8. PubMed ID: 2838785
[TBL] [Abstract][Full Text] [Related]
24. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
[TBL] [Abstract][Full Text] [Related]
25. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
[TBL] [Abstract][Full Text] [Related]
26. The potential of oncogene products as tumour markers.
Chan S; Sikora K
Cancer Surv; 1987; 6(2):185-207. PubMed ID: 3322544
[TBL] [Abstract][Full Text] [Related]
27. Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc.
Okuda T; Kondoh H
Biochem Biophys Res Commun; 1999 Dec; 266(1):208-15. PubMed ID: 10581191
[TBL] [Abstract][Full Text] [Related]
28. Isolation and characterization of Nmi, a novel partner of Myc proteins.
Bao J; Zervos AS
Oncogene; 1996 May; 12(10):2171-6. PubMed ID: 8668343
[TBL] [Abstract][Full Text] [Related]
29. Proteins encoded by the c-myc oncogene: analysis of c-myc protein degradation.
Lüscher B; Eisenman RN
Princess Takamatsu Symp; 1986; 17():291-301. PubMed ID: 3332017
[TBL] [Abstract][Full Text] [Related]
30. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
31. Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor.
Whitehead I; Kirk H; Kay R
Oncogene; 1995 Feb; 10(4):713-21. PubMed ID: 7862449
[TBL] [Abstract][Full Text] [Related]
32. The N-myc proto-oncogene: developmental expression and in vivo site-directed mutagenesis.
Stanton BR; Parada LF
Brain Pathol; 1992 Jan; 2(1):71-83. PubMed ID: 1341949
[TBL] [Abstract][Full Text] [Related]
33. Loss of transcriptional attenuation in N-myc is associated with progression towards a more malignant phenotype.
Xu L; Meng Y; Wallen R; DePinho RA
Oncogene; 1995 Nov; 11(9):1865-72. PubMed ID: 7478616
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
Huang A; Ho CS; Ponzielli R; Barsyte-Lovejoy D; Bouffet E; Picard D; Hawkins CE; Penn LZ
Cancer Res; 2005 Jul; 65(13):5607-19. PubMed ID: 15994933
[TBL] [Abstract][Full Text] [Related]
35. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
36. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
37. c-myc expression in the thyroid. I: Normal, adenomatous, and cancerous thyroid tissue.
Burman KD; Djuh YY; LaRocca RV; Nunes ME; D'Avis JC; Nicholson DE; Wartofsky L
Horm Metab Res Suppl; 1987; 17():63-5. PubMed ID: 3327800
[TBL] [Abstract][Full Text] [Related]
38. The human myc gene family: structure and activity of L-myc and an L-myc pseudogene.
DePinho RA; Hatton KS; Tesfaye A; Yancopoulos GD; Alt FW
Genes Dev; 1987 Dec; 1(10):1311-26. PubMed ID: 3322939
[TBL] [Abstract][Full Text] [Related]
39. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
40. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells.
Eilers M; Picard D; Yamamoto KR; Bishop JM
Nature; 1989 Jul; 340(6228):66-8. PubMed ID: 2662015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
